Supreme Court Questions Centre on Medicine Price Disparity

The Supreme Court on Tuesday questioned the Centre regarding a significant disparity in medicine pricing. The court highlighted the difference between the maximum retail price (MRP) of medicines and their cost to retailers.

This inquiry focused on why the current system appears to benefit pharmaceutical manufacturers, seemingly at the expense of patients. The Supreme Court's concern points to potential imbalances in the drug supply chain.

The court's intervention underscores ongoing scrutiny of medicine price markups. This critical examination by the Supreme Court aims to address fairness in healthcare costs for consumers.

What to watch: The Centre's response and any subsequent actions on medicine pricing.

Editor's note: The draft accurately captures the essence of the Supreme Court's inquiry and the core issue of price disparity reported in the summary.